• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

调节性 T 细胞的空间细胞相互作用网络可预测可手术非小细胞肺癌患者的复发情况。

Spatial cell interplay networks of regulatory T cells predict recurrence in patients with operable non-small cell lung cancer.

机构信息

Shandong University Cancer Center, Shandong University, Jinan, Shandong, China.

Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, and Shandong Academy of Medical Sciences, Jinan, Shandong, China.

出版信息

Cancer Immunol Immunother. 2024 Aug 2;73(10):189. doi: 10.1007/s00262-024-03762-x.

DOI:10.1007/s00262-024-03762-x
PMID:39093404
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11297009/
Abstract

BACKGROUND

The interplay between regulatory T cells (Tregs) and neighboring cells, which is pivotal for anti-tumor immunity and closely linked to patient prognosis, remains to be fully elucidated.

METHODS

Tissue microarrays of 261 operable NSCLC patients were stained by multiplex immunofluorescence (mIF) assay, and the interaction between Tregs and neighboring cells in the tumor microenvironment (TME) was evaluated. Employing various machine learning algorithms, we developed a spatial immune signature to predict the prognosis of NSCLC patients. Additionally, we explored the interplay between programmed death-1/programmed death ligand-1 (PD-1/PD-L1) interactions and their relationship with Tregs.

RESULTS

Survival analysis indicated that the interplay between Tregs and neighboring cells in the invasive margin (IM) and tumor center was associated with recurrence in NSCLC patients. We integrated the intersection of the three algorithms to identify four crucial spatial immune features [P in IM, P in IM, N in IM, N in IM] and employed these characteristics to establish SIS, an independent prognosticator of recurrence in NSCLC patients [HR = 2.34, 95% CI (1.53, 3.58), P < 0.001]. Furthermore, analysis of cell interactions demonstrated that a higher number of Tregs contributed to higher PD-L1 cells surrounded by PD-1 cells (P < 0.001) with shorter distances (P = 0.004).

CONCLUSION

We dissected the cell interplay network within the TME, uncovering the spatial architecture and intricate interactions between Tregs and neighboring cells, along with their impact on the prognosis of NSCLC patients.

摘要

背景

调节性 T 细胞(Tregs)与相邻细胞之间的相互作用对于抗肿瘤免疫至关重要,并且与患者的预后密切相关,但目前仍未完全阐明。

方法

对 261 例可手术的非小细胞肺癌(NSCLC)患者的组织微阵列进行多重免疫荧光(mIF)检测,并评估肿瘤微环境(TME)中 Tregs 与相邻细胞之间的相互作用。我们采用各种机器学习算法,开发了一种空间免疫特征来预测 NSCLC 患者的预后。此外,我们还探讨了程序性死亡受体-1/程序性死亡配体-1(PD-1/PD-L1)相互作用与其与 Tregs 之间的关系。

结果

生存分析表明,Tregs 与侵袭边缘(IM)和肿瘤中心的相邻细胞之间的相互作用与 NSCLC 患者的复发有关。我们整合了三种算法的交点,鉴定出四个关键的空间免疫特征[IM 中的 P、IM 中的 P、IM 中的 N、IM 中的 N],并利用这些特征建立了 SIS,这是非小细胞肺癌患者复发的独立预后指标[HR=2.34,95%CI(1.53,3.58),P<0.001]。此外,细胞相互作用分析表明,Tregs 数量的增加与 PD-1 细胞周围 PD-L1 细胞(P<0.001)和距离较短(P=0.004)有关。

结论

我们剖析了 TME 中的细胞相互作用网络,揭示了 Tregs 与相邻细胞之间的空间结构和复杂相互作用,以及它们对 NSCLC 患者预后的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7410/11297009/703f40f22921/262_2024_3762_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7410/11297009/b9294b100e64/262_2024_3762_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7410/11297009/1261eb3c10ad/262_2024_3762_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7410/11297009/bd218b149504/262_2024_3762_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7410/11297009/7f3dc705a142/262_2024_3762_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7410/11297009/703f40f22921/262_2024_3762_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7410/11297009/b9294b100e64/262_2024_3762_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7410/11297009/1261eb3c10ad/262_2024_3762_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7410/11297009/bd218b149504/262_2024_3762_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7410/11297009/7f3dc705a142/262_2024_3762_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7410/11297009/703f40f22921/262_2024_3762_Fig5_HTML.jpg

相似文献

1
Spatial cell interplay networks of regulatory T cells predict recurrence in patients with operable non-small cell lung cancer.调节性 T 细胞的空间细胞相互作用网络可预测可手术非小细胞肺癌患者的复发情况。
Cancer Immunol Immunother. 2024 Aug 2;73(10):189. doi: 10.1007/s00262-024-03762-x.
2
The role of spatial interplay patterns between PD-L1-positive tumor cell and T cell in recurrence of locally advanced non-small cell lung cancer.肿瘤细胞 PD-L1 阳性与 T 细胞之间空间相互作用模式在局部晚期非小细胞肺癌复发中的作用。
Cancer Immunol Immunother. 2023 Jul;72(7):2015-2027. doi: 10.1007/s00262-023-03380-z. Epub 2023 Feb 4.
3
Prognostic Impact of Programmed Death-ligand 1 and Surrounding Immune Status on Stage I Lung Cancer.程序性死亡配体 1 及其周围免疫状态对Ⅰ期肺癌的预后影响。
Clin Lung Cancer. 2020 Jul;21(4):e302-e314. doi: 10.1016/j.cllc.2020.01.013. Epub 2020 Jan 27.
4
Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.基质 PD-L1 阳性调节性 T 细胞和 PD-1 阳性 CD8 阳性 T 细胞定义了不同亚组非小细胞肺癌对 PD-1/PD-L1 阻断免疫治疗的反应。
J Thorac Oncol. 2018 Apr;13(4):521-532. doi: 10.1016/j.jtho.2017.11.132. Epub 2017 Dec 18.
5
SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation.Src 家族激酶(SFK)抑制剂达沙替尼通过抑制调节性 T 细胞(Treg)的转化和增殖,提高抗 PD-1 在 NSCLC 模型中的抗肿瘤活性。
J Immunother Cancer. 2021 Mar;9(3). doi: 10.1136/jitc-2020-001496.
6
Functional status and spatial architecture of tumor-infiltrating CD8+ T cells are associated with lymph node metastases in non-small cell lung cancer.肿瘤浸润 CD8+T 细胞的功能状态和空间结构与非小细胞肺癌的淋巴结转移相关。
J Transl Med. 2023 May 12;21(1):320. doi: 10.1186/s12967-023-04154-y.
7
Modified spatial architecture of regulatory T cells after neoadjuvant chemotherapy in non-small cell lung cancer patients.新辅助化疗后非小细胞肺癌患者调节性 T 细胞的空间结构改变。
Int Immunopharmacol. 2024 Aug 20;137:112434. doi: 10.1016/j.intimp.2024.112434. Epub 2024 Jun 17.
8
Tumor-associated macrophages and the tumor immune microenvironment of primary and recurrent epithelial ovarian cancer.原发性和复发性上皮性卵巢癌中的肿瘤相关巨噬细胞和肿瘤免疫微环境。
Hum Pathol. 2018 Apr;74:135-147. doi: 10.1016/j.humpath.2017.12.010. Epub 2017 Dec 27.
9
Assessing PDL-1 and PD-1 in Non-Small Cell Lung Cancer: A Novel Immunoscore Approach.评估非小细胞肺癌中的PDL-1和PD-1:一种新型免疫评分方法。
Clin Lung Cancer. 2017 Mar;18(2):220-233.e8. doi: 10.1016/j.cllc.2016.09.009. Epub 2016 Oct 5.
10
Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancer.非小细胞肺癌患者在接受 PD-1/PD-L1 阻断治疗期间出现超进展性疾病。
Ann Oncol. 2019 Jul 1;30(7):1104-1113. doi: 10.1093/annonc/mdz123.

引用本文的文献

1
Development and Validation of a Predictive Nomogram for Early Postoperative Recurrence in Non-Small Cell Lung Cancer.非小细胞肺癌术后早期复发预测列线图的开发与验证
Med Sci Monit. 2025 Jul 13;31:e948441. doi: 10.12659/MSM.948441.
2
Closer proximity of pre-treatment CD4 T cells to CD8 T cells favor response to neoadjuvant immunotherapy in patients with PD-L1 low-expressing non-small cell lung cancer.在程序性死亡配体1(PD-L1)低表达的非小细胞肺癌患者中,预处理时CD4 T细胞与CD8 T细胞的距离更近有利于对新辅助免疫疗法产生反应。
Transl Lung Cancer Res. 2025 Mar 31;14(3):810-823. doi: 10.21037/tlcr-24-886. Epub 2025 Mar 26.

本文引用的文献

1
CXCR3 expression in regulatory T cells drives interactions with type I dendritic cells in tumors to restrict CD8 T cell antitumor immunity.CXCR3 在调节性 T 细胞中的表达驱动其与肿瘤中 I 型树突状细胞的相互作用,从而限制 CD8 T 细胞的抗肿瘤免疫。
Immunity. 2023 Jul 11;56(7):1613-1630.e5. doi: 10.1016/j.immuni.2023.06.003. Epub 2023 Jun 30.
2
Dynamics and specificities of T cells in cancer immunotherapy.癌症免疫治疗中的 T 细胞动力学和特异性。
Nat Rev Cancer. 2023 May;23(5):295-316. doi: 10.1038/s41568-023-00560-y. Epub 2023 Apr 12.
3
Functional Engagement of the PD-1/PD-L1 Complex But Not PD-L1 Expression Is Highly Predictive of Patient Response to Immunotherapy in Non-Small-Cell Lung Cancer.
PD-1/PD-L1 复合物的功能性结合而非 PD-L1 表达高度预测非小细胞肺癌患者对免疫治疗的反应。
J Clin Oncol. 2023 May 10;41(14):2561-2570. doi: 10.1200/JCO.22.01748. Epub 2023 Feb 23.
4
Natural killer cells suppress cancer metastasis by eliminating circulating cancer cells.自然杀伤细胞通过消除循环中的癌细胞来抑制癌症转移。
Front Immunol. 2023 Jan 17;13:1098445. doi: 10.3389/fimmu.2022.1098445. eCollection 2022.
5
Identification of immune microenvironment subtypes and signature genes for Alzheimer's disease diagnosis and risk prediction based on explainable machine learning.基于可解释机器学习的阿尔茨海默病诊断和风险预测的免疫微环境亚型和特征基因的鉴定。
Front Immunol. 2022 Dec 8;13:1046410. doi: 10.3389/fimmu.2022.1046410. eCollection 2022.
6
Therapeutic targeting of PD-1/PD-L1 blockade by novel small-molecule inhibitors recruits cytotoxic T cells into solid tumor microenvironment.新型小分子抑制剂通过 PD-1/PD-L1 阻断的治疗靶向将细胞毒性 T 细胞募集到实体瘤微环境中。
J Immunother Cancer. 2022 Jul;10(7). doi: 10.1136/jitc-2022-004695.
7
Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments.乳酸在高度糖酵解的肿瘤微环境中促进调节性 T 细胞中 PD-1 的表达。
Cancer Cell. 2022 Feb 14;40(2):201-218.e9. doi: 10.1016/j.ccell.2022.01.001. Epub 2022 Jan 28.
8
Programmed death ligand 1 signals in cancer cells.程序性死亡配体 1 在癌细胞中的信号转导。
Nat Rev Cancer. 2022 Mar;22(3):174-189. doi: 10.1038/s41568-021-00431-4. Epub 2022 Jan 14.
9
The Immune Landscape of Human Primary Lung Tumors Is Th2 Skewed.人类原发性肺肿瘤的免疫景观呈 Th2 偏倚。
Front Immunol. 2021 Nov 18;12:764596. doi: 10.3389/fimmu.2021.764596. eCollection 2021.
10
Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies.调节性 T 细胞浸润肿瘤的机制:对创新免疫精准治疗的启示。
J Immunother Cancer. 2021 Jul;9(7). doi: 10.1136/jitc-2021-002591.